Both enantiomers of rolipram (1) have been prepared in large quantity
from a common intermediate rac-3-(3'-cyclopentyloxy-4'-methoxy)phenyl-
4-nitro butyric acid (6), which was resolved by way of the two readily
separable diastereoisomeric amides obtained with (S)-(-)-phenylethyla
mine. Reduction of the nitro group and intramolecular transamidation g
ave (R)-(-)-1 and (S)-(+)-1, respectively. CD spectra of both enantiom
ers of rolipram are reported and discussed. Both enantiomers of rolipr
am presented the same potency of inhibitory activity against recombina
nt cyclic-AMP-selective phosphodiesterase (PDE4) subtypes.